1. Home
  2. ARBB vs MBRX Comparison

ARBB vs MBRX Comparison

Compare ARBB & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

SELL

Current Price

$3.70

Market Cap

6.5M

Sector

Technology

ML Signal

SELL

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

N/A

Current Price

$7.05

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBB
MBRX
Founded
1997
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.4M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
ARBB
MBRX
Price
$3.70
$7.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $240.00
AVG Volume (30 Days)
5.3K
★ 35.7K
Earning Date
12-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$0.16
52 Week High
$10.67
$11.35

Technical Indicators

Market Signals
Indicator
ARBB
MBRX
Relative Strength Index (RSI) 41.58 55.72
Support Level $3.16 $2.12
Resistance Level $4.95 $10.24
Average True Range (ATR) 0.22 0.63
MACD -0.01 -0.43
Stochastic Oscillator 43.45 4.55

Price Performance

Historical Comparison
ARBB
MBRX

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: